Exodus Point Capital Management, LP Vericel Corp Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$29.0 - $38.37 $893,606 - $1.18 Million	-30,814 Reduced 72.43%	11,732 $441,000
Q1 2023 May 11, 2023	BUY	$23.85 - $31.34 $665,963 - $875,106	27,923 Added 190.95%	42,546 $1.25 Million
Q4 2022 Feb 13, 2023	BUY	$17.65 - $27.37 $96,368 - $149,440	5,460 Added 59.59%	14,623 $385,000
Q3 2022 Nov 10, 2022	BUY	$22.62 - $32.54 $207,267 - $298,164	9,163 New	9,163 $213,000
Q3 2021 Nov 15, 2021	SELL	$46.35 - $59.75 $391,518 - $504,708	-8,447 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$47.2 - $67.81 $398,698 - $572,791	8,447 New	8,447 $443,000
Q4 2020 Feb 16, 2021	SELL	$18.53 - $31.5 $488,043 - $829,647	-26,338 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$14.68 - $19.12 $386,641 - $503,582	26,338 New	26,338 $488,000

293

50.7M

98.2K

135K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.3B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.